Participated in Freedom Biosciences' $10.5M seed round alongside MBX Capital and Startup Yale.
Freedom Biosciences is a clinical-stage biotechnology platform developing next-generation neuropsychiatric therapeutics
Freedom Biosciences is a clinical-stage biotechnology platform developing next-generation neuropsychiatric therapeutics. The company focuses on creating innovative treatments for mental health disorders, leveraging a discovery platform to identify effective combinations of chemicals, including ketamine-based therapies.